It is shaking us all, to be blunt
A disease long understood as a companion of old age has quietly crossed a threshold, becoming the leading cancer killer of Americans under fifty — a shift so recent and so unexplained that it has unsettled even the physicians who have spent careers fighting it. Dr. John Marshall of Georgetown University, who once went years without seeing a young patient with colorectal cancer, now encounters them routinely in their twenties, thirties, and forties. Medicine has confirmed the pattern but cannot yet name its cause, leaving a generation to reckon with a risk they were never taught to carry.
- Colorectal cancer has overtaken all other cancers as the leading killer of Americans under fifty — a statistical crossing that would have seemed implausible a generation ago.
- Physicians who built careers on the assumption that young bodies were largely safe from this disease are now confronting waiting rooms that contradict everything they were trained to expect.
- The absence of a known cause is its own crisis: without understanding why this is happening, prevention strategies remain blunt and public health messaging stays frustratingly incomplete.
- Younger patients — people raising children, building careers, expecting decades ahead — are receiving diagnoses they were statistically unlikely to face, often after dismissing symptoms as something minor.
- In the absence of answers, the medical community is pivoting toward awareness: teaching younger adults to recognize gastrointestinal warning signs and to seek screening rather than wait for certainty.
Dr. John Marshall has spent more than thirty years treating cancer at Georgetown University's Lombardi Comprehensive Cancer Centre, and he says something fundamental has changed. Early in his career, a young patient with colorectal cancer was a rarity — memorable precisely because it almost never happened. Now, people in their twenties, thirties, and forties walk through his door with the disease regularly enough to constitute a pattern that shakes everyone in cancer care.
Colorectal cancer has become the leading cancer killer of Americans under fifty, a threshold that marks a profound shift in public health. For decades, the disease was understood as a condition of later life, something to screen for after fifty or sixty. That assumption no longer holds, and the medical establishment has been caught off guard by how quickly the landscape changed.
What makes the moment especially difficult is that no one can explain it. Environmental factors, dietary shifts, lifestyle changes, genetic predisposition, and infectious agents are all under investigation, but none has emerged as the clear cause. Without understanding the driver, prevention is harder to design and public health messaging harder to deliver with confidence.
The human cost is not abstract. People in the middle of their lives — raising families, building futures — are receiving diagnoses that the statistics once said were unlikely for their age group. The disease does not honor old assumptions. For now, the medical community is focusing on what it can offer: awareness of symptoms, encouragement to take gastrointestinal changes seriously, and a fundamental reframing of who belongs in the at-risk population. The question of why remains, for the moment, unanswered.
A doctor who has spent more than thirty years treating cancer patients says something has shifted in his practice in ways that still unsettle him. Dr. John Marshall, who works at the Lombardi Comprehensive Cancer Centre at Georgetown University in Washington, now regularly sees people in their twenties, thirties, and forties walking through his door with colorectal cancer. When he started his career, this almost never happened. Young people simply did not get this disease.
Today, colorectal cancer has become the leading cancer killer of Americans under fifty. It is a threshold moment in public health—a disease long associated with aging has begun claiming younger lives at rates that have caught the medical establishment off guard. Marshall, who also serves as a medical consultant to the Colorectal Cancer Alliance, the nation's largest nonprofit focused on this disease, describes the trend plainly: it is shaking everyone involved in cancer care.
The surge is real, but its cause remains a mystery. No one in the medical community has a clear answer for why this is happening now, in this generation. The absence of explanation is itself part of what makes the moment urgent. Without understanding the driver, prevention becomes harder. Screening becomes more complicated. Public health messaging becomes uncertain.
What makes this shift particularly striking is how recent it is. For decades, colorectal cancer was understood as a disease of later life, something to watch for after fifty or sixty. Younger patients were rare enough that they stood out in a doctor's practice. Now they are common enough to constitute a trend, to warrant national attention, to change how the medical system thinks about risk.
The human dimension of this shift is substantial. People in their prime working years, people raising families, people who thought they had decades ahead of them, are receiving diagnoses that were supposed to be rare in their age group. The disease does not discriminate based on what the statistics used to say. It simply appears, often with symptoms that younger people might not recognize as urgent, or might attribute to something else entirely.
For now, the medical community is focused on awareness and early detection. If the cause cannot yet be identified, at least the symptoms can be known. At least people can be taught to listen to their bodies, to take gastrointestinal changes seriously, to seek screening if they notice warning signs. The conversation has shifted from "this is an old person's disease" to "this can happen to anyone, and here is what to watch for."
The question of why remains open. Environmental factors, dietary changes, lifestyle shifts, genetic predisposition, infectious agents—all of these are possibilities under investigation. But none has emerged as the clear culprit. What is certain is that the pattern is undeniable, and that younger Americans now need to understand themselves as part of the population at risk.
Notable Quotes
At the beginning of my career, nobody that age had colorectal cancer. Now we're seeing more and more people in their 20s, 30s, and 40s developing it.— Dr. John Marshall, Lombardi Comprehensive Cancer Centre
This trend is shaking us all, to be blunt— Dr. John Marshall
The Hearth Conversation Another angle on the story
Why do you think doctors are so unsettled by this trend? It's just a shift in disease patterns.
Because it violates what they thought they knew. For thirty years, Marshall didn't see this. Now he does regularly. That's not a small thing—it means something in the world changed, and we don't know what.
But couldn't it just be better detection? Maybe young people always had it, and now we're finding it?
Possibly. But the data suggests real increases, not just earlier diagnosis. And even if some of it is detection, that still means young people are getting sick in ways they weren't before.
What's the scariest part of not knowing the cause?
You can't prevent what you don't understand. You can screen, you can educate, but you're always one step behind. You're treating the symptom, not the disease.
So what do doctors tell a thirty-year-old who comes in worried?
They take them seriously now. That's the change. Ten years ago, maybe they would have dismissed it. Now they know better. But they still can't say why it's happening.
Does that uncertainty make people more or less likely to get screened?
That's the real question. Fear can drive screening. But so can hope that it won't happen to you. Right now, young people are caught between those two things.